

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium or flagellum-dependent cell motility (GO:0001539) | 9.78422032 |
| 2 | motile cilium assembly (GO:0044458) | 7.96464100 |
| 3 | cilium movement (GO:0003341) | 7.73734013 |
| 4 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 6.57778421 |
| 5 | keratan sulfate catabolic process (GO:0042340) | 6.56664725 |
| 6 | epithelial cilium movement (GO:0003351) | 6.18787472 |
| 7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.16748146 |
| 8 | urate metabolic process (GO:0046415) | 6.12071326 |
| 9 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 6.04910965 |
| 10 | drug transmembrane transport (GO:0006855) | 5.90745742 |
| 11 | organic cation transport (GO:0015695) | 5.75813725 |
| 12 | primary alcohol catabolic process (GO:0034310) | 5.33281567 |
| 13 | drug transport (GO:0015893) | 5.19931789 |
| 14 | left/right pattern formation (GO:0060972) | 5.19083222 |
| 15 | cell aggregation (GO:0098743) | 4.94347122 |
| 16 | cartilage condensation (GO:0001502) | 4.94347122 |
| 17 | ethanol metabolic process (GO:0006067) | 4.84964537 |
| 18 | axoneme assembly (GO:0035082) | 4.81424386 |
| 19 | phosphate ion transport (GO:0006817) | 4.71800491 |
| 20 | renal absorption (GO:0070293) | 4.69360696 |
| 21 | chondrocyte development (GO:0002063) | 4.68295552 |
| 22 | vitamin transmembrane transport (GO:0035461) | 4.66717155 |
| 23 | excretion (GO:0007588) | 4.65455491 |
| 24 | diterpenoid biosynthetic process (GO:0016102) | 4.63752110 |
| 25 | iron ion import (GO:0097286) | 4.39310258 |
| 26 | metanephric tubule development (GO:0072170) | 4.27822137 |
| 27 | metanephric nephron tubule development (GO:0072234) | 4.27822137 |
| 28 | metanephric nephron epithelium development (GO:0072243) | 4.20731336 |
| 29 | positive regulation of extracellular matrix organization (GO:1903055) | 4.20250508 |
| 30 | lung epithelium development (GO:0060428) | 4.19197340 |
| 31 | lysine catabolic process (GO:0006554) | 4.18749220 |
| 32 | lysine metabolic process (GO:0006553) | 4.18749220 |
| 33 | quaternary ammonium group transport (GO:0015697) | 4.15915388 |
| 34 | cellular response to vitamin D (GO:0071305) | 4.15063400 |
| 35 | collagen fibril organization (GO:0030199) | 4.13267001 |
| 36 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.11546442 |
| 37 | toxin transport (GO:1901998) | 4.00879324 |
| 38 | ethanol oxidation (GO:0006069) | 4.00042531 |
| 39 | response to mercury ion (GO:0046689) | 3.97088351 |
| 40 | notochord development (GO:0030903) | 3.91875681 |
| 41 | regulation of apoptotic cell clearance (GO:2000425) | 3.85493759 |
| 42 | vitamin D metabolic process (GO:0042359) | 3.84642060 |
| 43 | establishment of apical/basal cell polarity (GO:0035089) | 3.84451794 |
| 44 | metanephric epithelium development (GO:0072207) | 3.83453468 |
| 45 | phosphate ion transmembrane transport (GO:0035435) | 3.80392993 |
| 46 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.79811788 |
| 47 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.75898133 |
| 48 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.75802953 |
| 49 | response to magnesium ion (GO:0032026) | 3.75782431 |
| 50 | nephron tubule formation (GO:0072079) | 3.72251697 |
| 51 | nephron tubule development (GO:0072080) | 3.71922004 |
| 52 | negative regulation of humoral immune response (GO:0002921) | 3.71830091 |
| 53 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.67027103 |
| 54 | protein carboxylation (GO:0018214) | 3.67027103 |
| 55 | response to vitamin D (GO:0033280) | 3.63530857 |
| 56 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.59602185 |
| 57 | oligosaccharide catabolic process (GO:0009313) | 3.59381532 |
| 58 | fibrinolysis (GO:0042730) | 3.58309881 |
| 59 | cellular response to vitamin (GO:0071295) | 3.52399151 |
| 60 | glomerular epithelial cell development (GO:0072310) | 3.51982816 |
| 61 | trivalent inorganic anion homeostasis (GO:0072506) | 3.51010062 |
| 62 | phosphate ion homeostasis (GO:0055062) | 3.51010062 |
| 63 | limb bud formation (GO:0060174) | 3.50502892 |
| 64 | collagen catabolic process (GO:0030574) | 3.49795585 |
| 65 | left/right axis specification (GO:0070986) | 3.46302563 |
| 66 | response to xenobiotic stimulus (GO:0009410) | 3.43367716 |
| 67 | collagen metabolic process (GO:0032963) | 3.42854326 |
| 68 | endothelial cell morphogenesis (GO:0001886) | 3.42637102 |
| 69 | exogenous drug catabolic process (GO:0042738) | 3.41786720 |
| 70 | cysteine metabolic process (GO:0006534) | 3.37536773 |
| 71 | regulation of extracellular matrix disassembly (GO:0010715) | 3.32650837 |
| 72 | hemidesmosome assembly (GO:0031581) | 3.31378153 |
| 73 | glucuronate metabolic process (GO:0019585) | 3.30747091 |
| 74 | uronic acid metabolic process (GO:0006063) | 3.30747091 |
| 75 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.29953481 |
| 76 | glycoside metabolic process (GO:0016137) | 3.29447446 |
| 77 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.28317233 |
| 78 | microtubule bundle formation (GO:0001578) | 3.27789420 |
| 79 | polyol transport (GO:0015791) | 3.27324313 |
| 80 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.26908227 |
| 81 | ventricular system development (GO:0021591) | 3.25824337 |
| 82 | cartilage development (GO:0051216) | 3.25608353 |
| 83 | multicellular organismal catabolic process (GO:0044243) | 3.25502210 |
| 84 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.24009557 |
| 85 | nephron epithelium development (GO:0072009) | 3.21023712 |
| 86 | sodium-independent organic anion transport (GO:0043252) | 3.20548795 |
| 87 | drug catabolic process (GO:0042737) | 3.19951246 |
| 88 | regulation of cilium movement (GO:0003352) | 3.18256615 |
| 89 | renal tubule development (GO:0061326) | 3.18077200 |
| 90 | modified amino acid transport (GO:0072337) | 3.15951391 |
| 91 | apoptotic cell clearance (GO:0043277) | 3.14782970 |
| 92 | negative regulation of fibrinolysis (GO:0051918) | 3.14679133 |
| 93 | peptide catabolic process (GO:0043171) | 3.14427282 |
| 94 | multicellular organismal metabolic process (GO:0044236) | 3.13764599 |
| 95 | cellular glucuronidation (GO:0052695) | 3.13312213 |
| 96 | chondrocyte differentiation (GO:0002062) | 3.12854319 |
| 97 | regulation of protein activation cascade (GO:2000257) | 3.11050712 |
| 98 | cell-cell junction maintenance (GO:0045217) | 3.09570325 |
| 99 | semaphorin-plexin signaling pathway (GO:0071526) | 3.08892362 |
| 100 | regulation of complement activation (GO:0030449) | 3.08235377 |
| 101 | endochondral ossification (GO:0001958) | 3.07928487 |
| 102 | replacement ossification (GO:0036075) | 3.07928487 |
| 103 | retinoic acid metabolic process (GO:0042573) | 3.07541791 |
| 104 | glyoxylate metabolic process (GO:0046487) | 3.02843416 |
| 105 | positive regulation of chondrocyte differentiation (GO:0032332) | 3.02043790 |
| 106 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.01442616 |
| 107 | establishment of monopolar cell polarity (GO:0061162) | 3.01442616 |
| 108 | chondrocyte proliferation (GO:0035988) | 3.01258397 |
| 109 | carnitine transport (GO:0015879) | 3.00962766 |
| 110 | amino-acid betaine transport (GO:0015838) | 3.00962766 |
| 111 | multicellular organismal water homeostasis (GO:0050891) | 3.00333128 |
| 112 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.98064725 |
| 113 | extracellular matrix disassembly (GO:0022617) | 2.97736634 |
| 114 | bone remodeling (GO:0046849) | 2.97153624 |
| 115 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.96999447 |
| 116 | basement membrane organization (GO:0071711) | 2.95513918 |
| 117 | sulfur compound catabolic process (GO:0044273) | 2.94248671 |
| 118 | negative regulation of lipase activity (GO:0060192) | 2.94210112 |
| 119 | ear development (GO:0043583) | 2.93277058 |
| 120 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.92977076 |
| 121 | proline metabolic process (GO:0006560) | 2.92237990 |
| 122 | phospholipid efflux (GO:0033700) | 2.91317045 |
| 123 | one-carbon compound transport (GO:0019755) | 2.89639713 |
| 124 | protein retention in ER lumen (GO:0006621) | 2.87668679 |
| 125 | negative regulation of sterol transport (GO:0032372) | 2.87313672 |
| 126 | negative regulation of cholesterol transport (GO:0032375) | 2.87313672 |
| 127 | establishment of planar polarity (GO:0001736) | 2.87066317 |
| 128 | establishment of tissue polarity (GO:0007164) | 2.87066317 |
| 129 | regulation of fibrinolysis (GO:0051917) | 2.85969268 |
| 130 | response to parathyroid hormone (GO:0071107) | 2.84470340 |
| 131 | complement activation, alternative pathway (GO:0006957) | 2.84301018 |
| 132 | glutathione biosynthetic process (GO:0006750) | 2.83788135 |
| 133 | positive regulation of cartilage development (GO:0061036) | 2.82461765 |
| 134 | regulation of extracellular matrix organization (GO:1903053) | 2.82446685 |
| 135 | vitamin catabolic process (GO:0009111) | 2.81927422 |
| 136 | fat-soluble vitamin catabolic process (GO:0042363) | 2.81927422 |
| 137 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.81358175 |
| 138 | short-chain fatty acid metabolic process (GO:0046459) | 2.80969307 |
| 139 | proteoglycan metabolic process (GO:0006029) | 2.80340639 |
| 140 | negative regulation of hemostasis (GO:1900047) | 2.79751395 |
| 141 | negative regulation of blood coagulation (GO:0030195) | 2.79751395 |
| 142 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.76627041 |
| 143 | Notch signaling involved in heart development (GO:0061314) | 2.75372722 |
| 144 | surfactant homeostasis (GO:0043129) | 2.74696353 |
| 145 | response to lead ion (GO:0010288) | 2.74675030 |
| 146 | regulation of plasminogen activation (GO:0010755) | 2.72427182 |
| 147 | barbed-end actin filament capping (GO:0051016) | 2.71401264 |
| 148 | negative regulation of coagulation (GO:0050819) | 2.70843792 |
| 149 | tricarboxylic acid metabolic process (GO:0072350) | 2.70554502 |
| 150 | regulation of cholesterol esterification (GO:0010872) | 2.69525787 |
| 151 | positive regulation of hormone metabolic process (GO:0032352) | 2.69250949 |
| 152 | bone resorption (GO:0045453) | 2.69206641 |
| 153 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.68389813 |
| 154 | vitamin transport (GO:0051180) | 2.67262931 |
| 155 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.66848041 |
| 156 | sulfur compound transport (GO:0072348) | 2.66746226 |
| 157 | valine metabolic process (GO:0006573) | 2.66510045 |
| 158 | terpenoid biosynthetic process (GO:0016114) | 2.66291944 |
| 159 | primary alcohol metabolic process (GO:0034308) | 2.65493816 |
| 160 | tolerance induction (GO:0002507) | 2.60465429 |
| 161 | water homeostasis (GO:0030104) | 2.59805850 |
| 162 | cell junction maintenance (GO:0034331) | 2.58257053 |
| 163 | epoxygenase P450 pathway (GO:0019373) | 2.56419453 |
| 164 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.56216758 |
| 165 | epithelial cell-cell adhesion (GO:0090136) | 2.53682117 |
| 166 | regulation of metalloenzyme activity (GO:0048552) | 2.50745555 |
| 167 | embryo implantation (GO:0007566) | 2.50210520 |
| 168 | cholesterol efflux (GO:0033344) | 2.50182851 |
| 169 | COPI coating of Golgi vesicle (GO:0048205) | 2.45305984 |
| 170 | Golgi transport vesicle coating (GO:0048200) | 2.45305984 |
| 171 | desmosome organization (GO:0002934) | 2.44893916 |
| 172 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.44789290 |
| 173 | negative regulation of B cell mediated immunity (GO:0002713) | 2.44789290 |
| 174 | negative regulation of wound healing (GO:0061045) | 2.44069539 |
| 175 | negative regulation of lipid transport (GO:0032369) | 2.43277863 |
| 176 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.43129082 |
| 177 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.42573281 |
| 178 | retinol metabolic process (GO:0042572) | 2.42216748 |
| 179 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.41579492 |
| 180 | regulation of humoral immune response (GO:0002920) | 2.40150062 |
| 181 | amyloid precursor protein catabolic process (GO:0042987) | 2.39625208 |
| 182 | high-density lipoprotein particle remodeling (GO:0034375) | 2.38154431 |
| 183 | O-glycan processing (GO:0016266) | 2.37950442 |
| 184 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.37861713 |
| 185 | protein localization to endosome (GO:0036010) | 2.37581835 |
| 186 | apical protein localization (GO:0045176) | 2.31866262 |
| 187 | hyaluronan metabolic process (GO:0030212) | 2.28210810 |
| 188 | sperm capacitation (GO:0048240) | 2.26262546 |
| 189 | L-ascorbic acid metabolic process (GO:0019852) | 2.25062124 |
| 190 | axonemal dynein complex assembly (GO:0070286) | 11.6504216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.85465353 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.31713978 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.52977519 |
| 4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.37916751 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.70502293 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.51130298 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.02224253 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.28331970 |
| 9 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.28271967 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.22442884 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08662882 |
| 12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.02760076 |
| 13 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.94233752 |
| 14 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90122533 |
| 15 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.89813784 |
| 16 | CJUN_26792858_Chip-Seq_BT549_Human | 1.88803591 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82486739 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.79701130 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78503822 |
| 20 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.70654093 |
| 21 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.68618272 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.68592923 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63806929 |
| 24 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.62034224 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60957796 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60841794 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.57049318 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54909552 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54567814 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51011415 |
| 31 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.49995670 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49105955 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46939010 |
| 34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45829323 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45534633 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45396074 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45396074 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45234427 |
| 39 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.44538880 |
| 40 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43959544 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41805710 |
| 42 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.40646655 |
| 43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39968528 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.38538295 |
| 45 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.38538295 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38185440 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37919045 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37468520 |
| 49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36227968 |
| 50 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35067790 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34455576 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34296173 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34132428 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.33804309 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33738545 |
| 56 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33338052 |
| 57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.31374571 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30175132 |
| 59 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29598330 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28560140 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28547595 |
| 62 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.28349553 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26139928 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25849387 |
| 65 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.24889795 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21355120 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20288737 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20288737 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19829966 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18539674 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.18086789 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17406712 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17019658 |
| 74 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15645922 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15607351 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15364689 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14871338 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14725349 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14612039 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14190263 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13205787 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12810034 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11845059 |
| 84 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.09314627 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08834274 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08243817 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08099381 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07445903 |
| 89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07147762 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07067263 |
| 91 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07011241 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06762109 |
| 93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06696030 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06173639 |
| 95 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05854059 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05423357 |
| 97 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03120811 |
| 98 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03057077 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02798017 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01056965 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00435275 |
| 102 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99862521 |
| 103 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.98979574 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98900324 |
| 105 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98764367 |
| 106 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97986639 |
| 107 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97954922 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97533456 |
| 109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97452182 |
| 110 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96906688 |
| 111 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96466320 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96346245 |
| 113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95317035 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95224000 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93986153 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93678994 |
| 117 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93518119 |
| 118 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93156169 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92971478 |
| 120 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.92968491 |
| 121 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92370549 |
| 122 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.91926778 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91314867 |
| 124 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90091316 |
| 125 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90091316 |
| 126 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90022434 |
| 127 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88497506 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88485790 |
| 129 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87410251 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87209139 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87208931 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86290325 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85659265 |
| 134 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.85508345 |
| 135 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84471015 |
| 136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83556630 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83283219 |
| 138 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82867375 |
| 139 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82616007 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81506647 |
| 141 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81092921 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80927279 |
| 143 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80607833 |
| 144 | ATF3_27146783_Chip-Seq_COLON_Human | 0.80242584 |
| 145 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.79946853 |
| 146 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.78094159 |
| 147 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77829406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 3.64760054 |
| 2 | MP0002933_joint_inflammation | 3.19249556 |
| 3 | MP0005503_abnormal_tendon_morphology | 3.14996427 |
| 4 | MP0005360_urolithiasis | 3.14892962 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.13630960 |
| 6 | MP0009840_abnormal_foam_cell | 2.96796003 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 2.93562503 |
| 8 | MP0001958_emphysema | 2.90932210 |
| 9 | MP0002282_abnormal_trachea_morphology | 2.90777396 |
| 10 | MP0003195_calcinosis | 2.83164642 |
| 11 | MP0004134_abnormal_chest_morphology | 2.71227299 |
| 12 | MP0000163_abnormal_cartilage_morphology | 2.64078872 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.50550310 |
| 14 | MP0003878_abnormal_ear_physiology | 2.50550310 |
| 15 | MP0009643_abnormal_urine_homeostasis | 2.48991935 |
| 16 | MP0002132_abnormal_respiratory_system | 2.47992046 |
| 17 | MP0005365_abnormal_bile_salt | 2.47244262 |
| 18 | MP0005332_abnormal_amino_acid | 2.43147978 |
| 19 | MP0001765_abnormal_ion_homeostasis | 2.41034249 |
| 20 | MP0003646_muscle_fatigue | 2.33200624 |
| 21 | MP0002115_abnormal_skeleton_extremities | 2.31453950 |
| 22 | MP0001756_abnormal_urination | 2.30533819 |
| 23 | MP0002896_abnormal_bone_mineralization | 2.29628614 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 2.27711216 |
| 25 | MP0002136_abnormal_kidney_physiology | 2.27094586 |
| 26 | MP0005275_abnormal_skin_tensile | 2.20313601 |
| 27 | MP0004272_abnormal_basement_membrane | 2.11087710 |
| 28 | MP0000762_abnormal_tongue_morphology | 2.09853521 |
| 29 | MP0009250_abnormal_appendicular_skeleto | 2.08359863 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.95268148 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.93337697 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.92492366 |
| 33 | MP0004133_heterotaxia | 1.88218505 |
| 34 | MP0002113_abnormal_skeleton_development | 1.85779951 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.82817704 |
| 36 | MP0004858_abnormal_nervous_system | 1.80759624 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.80758911 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.75363493 |
| 39 | MP0005508_abnormal_skeleton_morphology | 1.72561070 |
| 40 | MP0001270_distended_abdomen | 1.70225344 |
| 41 | MP0002089_abnormal_postnatal_growth/wei | 1.69707750 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.68828289 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.66991866 |
| 44 | MP0002139_abnormal_hepatobiliary_system | 1.64775372 |
| 45 | MP0000538_abnormal_urinary_bladder | 1.59562836 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.59070333 |
| 47 | MP0005390_skeleton_phenotype | 1.58342874 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.55762040 |
| 49 | MP0003283_abnormal_digestive_organ | 1.54437711 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 1.54180109 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 1.52740154 |
| 52 | MP0000467_abnormal_esophagus_morphology | 1.52180996 |
| 53 | MP0003795_abnormal_bone_structure | 1.51857749 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.45633054 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.40984484 |
| 56 | MP0008004_abnormal_stomach_pH | 1.38672049 |
| 57 | MP0009278_abnormal_bone_marrow | 1.37360944 |
| 58 | MP0002108_abnormal_muscle_morphology | 1.33089358 |
| 59 | MP0003941_abnormal_skin_development | 1.32431002 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.31850673 |
| 61 | MP0005083_abnormal_biliary_tract | 1.30249929 |
| 62 | MP0009384_cardiac_valve_regurgitation | 1.30190492 |
| 63 | MP0003252_abnormal_bile_duct | 1.29681373 |
| 64 | MP0005164_abnormal_response_to | 1.28383095 |
| 65 | MP0000858_altered_metastatic_potential | 1.28256961 |
| 66 | MP0001542_abnormal_bone_strength | 1.28246451 |
| 67 | MP0000604_amyloidosis | 1.25447356 |
| 68 | MP0002098_abnormal_vibrissa_morphology | 1.25205108 |
| 69 | MP0002109_abnormal_limb_morphology | 1.24411066 |
| 70 | MP0002168_other_aberrant_phenotype | 1.21465181 |
| 71 | MP0001299_abnormal_eye_distance/ | 1.18288524 |
| 72 | MP0003303_peritoneal_inflammation | 1.16183413 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.16009584 |
| 74 | MP0003186_abnormal_redox_activity | 1.15081323 |
| 75 | MP0003279_aneurysm | 1.14430758 |
| 76 | MP0001666_abnormal_nutrient_absorption | 1.13706443 |
| 77 | MP0000383_abnormal_hair_follicle | 1.09076819 |
| 78 | MP0002796_impaired_skin_barrier | 1.08189758 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.08002467 |
| 80 | MP0002060_abnormal_skin_morphology | 1.07543778 |
| 81 | MP0010030_abnormal_orbit_morphology | 1.06805654 |
| 82 | MP0005408_hypopigmentation | 1.06730838 |
| 83 | MP0003436_decreased_susceptibility_to | 1.05286135 |
| 84 | MP0003075_altered_response_to | 1.05223724 |
| 85 | MP0008260_abnormal_autophagy | 1.04750581 |
| 86 | MP0002928_abnormal_bile_duct | 1.03515835 |
| 87 | MP0005076_abnormal_cell_differentiation | 1.02867370 |
| 88 | MP0006082_CNS_inflammation | 1.02107409 |
| 89 | MP0000534_abnormal_ureter_morphology | 1.01984683 |
| 90 | MP0000432_abnormal_head_morphology | 0.99753496 |
| 91 | MP0005395_other_phenotype | 0.98988215 |
| 92 | MP0000751_myopathy | 0.96764566 |
| 93 | MP0005023_abnormal_wound_healing | 0.95884807 |
| 94 | MP0002116_abnormal_craniofacial_bone | 0.95863098 |
| 95 | MP0005451_abnormal_body_composition | 0.95549679 |
| 96 | MP0000566_synostosis | 0.94525321 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.92472066 |
| 98 | MP0005409_darkened_coat_color | 0.92162654 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.92109216 |
| 100 | MP0006054_spinal_hemorrhage | 0.90735536 |
| 101 | MP0000678_abnormal_parathyroid_gland | 0.90672842 |
| 102 | MP0010678_abnormal_skin_adnexa | 0.90170965 |
| 103 | MP0003329_amyloid_beta_deposits | 0.90147230 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.90092702 |
| 105 | MP0003755_abnormal_palate_morphology | 0.89946746 |
| 106 | MP0001915_intracranial_hemorrhage | 0.89488214 |
| 107 | MP0002135_abnormal_kidney_morphology | 0.89429819 |
| 108 | MP0000343_altered_response_to | 0.88108360 |
| 109 | MP0002254_reproductive_system_inflammat | 0.87821516 |
| 110 | MP0005165_increased_susceptibility_to | 0.84819072 |
| 111 | MP0004883_abnormal_blood_vessel | 0.82960445 |
| 112 | MP0001849_ear_inflammation | 0.82956457 |
| 113 | MP0000049_abnormal_middle_ear | 0.81994186 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.81792709 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.81582399 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.80883934 |
| 117 | MP0002233_abnormal_nose_morphology | 0.80732519 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.80298836 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.79493002 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.78550634 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.77957754 |
| 122 | MP0002111_abnormal_tail_morphology | 0.75376456 |
| 123 | MP0004947_skin_inflammation | 0.75288681 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.74928173 |
| 125 | MP0005501_abnormal_skin_physiology | 0.74771010 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.74262949 |
| 127 | MP0003091_abnormal_cell_migration | 0.74080119 |
| 128 | MP0004885_abnormal_endolymph | 0.72716488 |
| 129 | MP0000377_abnormal_hair_follicle | 0.72271434 |
| 130 | MP0001984_abnormal_olfaction | 0.71441744 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.71133086 |
| 132 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69841490 |
| 133 | MP0000249_abnormal_blood_vessel | 0.69135210 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.69128918 |
| 135 | MP0009053_abnormal_anal_canal | 0.68013171 |
| 136 | MP0002419_abnormal_innate_immunity | 0.67344327 |
| 137 | MP0003634_abnormal_glial_cell | 0.67156430 |
| 138 | MP0003942_abnormal_urinary_system | 0.64978936 |
| 139 | MP0005623_abnormal_meninges_morphology | 0.64246512 |
| 140 | MP0005670_abnormal_white_adipose | 0.62963348 |
| 141 | MP0002932_abnormal_joint_morphology | 0.62494831 |
| 142 | MP0005367_renal/urinary_system_phenotyp | 0.61993051 |
| 143 | MP0000516_abnormal_urinary_system | 0.61993051 |
| 144 | MP0005381_digestive/alimentary_phenotyp | 0.61860756 |
| 145 | MP0001663_abnormal_digestive_system | 0.61586865 |
| 146 | MP0005084_abnormal_gallbladder_morpholo | 0.61309680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 9.51543908 |
| 2 | Abnormal respiratory epithelium morphology (HP:0012253) | 8.37386749 |
| 3 | Abnormal respiratory motile cilium morphology (HP:0005938) | 8.37386749 |
| 4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 8.12579181 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 8.07329403 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 8.07329403 |
| 7 | Abnormal ciliary motility (HP:0012262) | 7.93510919 |
| 8 | Rhinitis (HP:0012384) | 7.40745801 |
| 9 | * Epiphyseal dysplasia (HP:0002656) | 7.25643314 |
| 10 | Delayed epiphyseal ossification (HP:0002663) | 6.21841642 |
| 11 | Irregular epiphyses (HP:0010582) | 5.88911734 |
| 12 | Nasal polyposis (HP:0100582) | 5.86078295 |
| 13 | Chronic bronchitis (HP:0004469) | 5.80042621 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 5.50315758 |
| 15 | Abnormal tarsal ossification (HP:0008369) | 5.31555269 |
| 16 | Bronchiectasis (HP:0002110) | 5.25442592 |
| 17 | Vitreoretinal degeneration (HP:0000655) | 5.05958520 |
| 18 | Metaphyseal cupping (HP:0003021) | 5.02168215 |
| 19 | Small epiphyses (HP:0010585) | 4.67916663 |
| 20 | Hypoplastic ischia (HP:0003175) | 4.59357745 |
| 21 | Cupped ribs (HP:0000887) | 4.40273045 |
| 22 | Neonatal short-limb short stature (HP:0008921) | 4.38091485 |
| 23 | Abnormality of the ischium (HP:0003174) | 4.02187876 |
| 24 | Abnormal foot bone ossification (HP:0010675) | 3.99360688 |
| 25 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.98509503 |
| 26 | * Genu varum (HP:0002970) | 3.98243732 |
| 27 | Hypokalemic alkalosis (HP:0001949) | 3.91802625 |
| 28 | Flat capital femoral epiphysis (HP:0003370) | 3.90916477 |
| 29 | Metabolic alkalosis (HP:0200114) | 3.88922016 |
| 30 | Enlarged epiphyses (HP:0010580) | 3.82709808 |
| 31 | Increased circulating renin level (HP:0000848) | 3.79089605 |
| 32 | Hyperactive renin-angiotensin system (HP:0000841) | 3.75644526 |
| 33 | Metaphyseal dysplasia (HP:0100255) | 3.74548994 |
| 34 | Cervical subluxation (HP:0003308) | 3.66973106 |
| 35 | Male infertility (HP:0003251) | 3.62568738 |
| 36 | Mild short stature (HP:0003502) | 3.60860362 |
| 37 | Abnormality of chloride homeostasis (HP:0011422) | 3.50907309 |
| 38 | * Flat acetabular roof (HP:0003180) | 3.45017798 |
| 39 | Hypomagnesemia (HP:0002917) | 3.42919414 |
| 40 | Polyuria (HP:0000103) | 3.35879239 |
| 41 | Gout (HP:0001997) | 3.29247853 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.28583538 |
| 43 | Infertility (HP:0000789) | 3.27761124 |
| 44 | Recurrent otitis media (HP:0000403) | 3.25124394 |
| 45 | Recurrent sinusitis (HP:0011108) | 3.21069962 |
| 46 | Atelectasis (HP:0100750) | 3.16772222 |
| 47 | Tetany (HP:0001281) | 3.14408691 |
| 48 | Abnormal urine output (HP:0012590) | 3.11006130 |
| 49 | Abnormality of renal excretion (HP:0011036) | 3.10726265 |
| 50 | Abnormality of femoral epiphyses (HP:0006499) | 3.08366297 |
| 51 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 3.08366297 |
| 52 | Osteoarthritis (HP:0002758) | 3.05949164 |
| 53 | Abnormality of the vertebral endplates (HP:0005106) | 3.05683866 |
| 54 | Flattened epiphyses (HP:0003071) | 3.05003385 |
| 55 | Protuberant abdomen (HP:0001538) | 3.03444575 |
| 56 | * Metaphyseal irregularity (HP:0003025) | 3.01907776 |
| 57 | Bronchitis (HP:0012387) | 2.96416844 |
| 58 | * Abnormality of carpal bone ossification (HP:0006257) | 2.89135530 |
| 59 | * Platyspondyly (HP:0000926) | 2.86473533 |
| 60 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.81304898 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.78841993 |
| 62 | Abnormality of magnesium homeostasis (HP:0004921) | 2.78162740 |
| 63 | Hyperuricemia (HP:0002149) | 2.76103300 |
| 64 | Increased purine levels (HP:0004368) | 2.76103300 |
| 65 | Proximal tubulopathy (HP:0000114) | 2.75823555 |
| 66 | Arthropathy (HP:0003040) | 2.71451315 |
| 67 | Hypercalciuria (HP:0002150) | 2.70561761 |
| 68 | Hydroxyprolinuria (HP:0003080) | 2.70031555 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 2.70031555 |
| 70 | Ovoid vertebral bodies (HP:0003300) | 2.68583281 |
| 71 | Irregular vertebral endplates (HP:0003301) | 2.68462112 |
| 72 | Chronic sinusitis (HP:0011109) | 2.67277578 |
| 73 | Occipital encephalocele (HP:0002085) | 2.66756242 |
| 74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66627190 |
| 75 | Beaking of vertebral bodies (HP:0004568) | 2.62087355 |
| 76 | Absent epiphyses (HP:0010577) | 2.61833555 |
| 77 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.61833555 |
| 78 | Abnormality of the femoral head (HP:0003368) | 2.59440471 |
| 79 | Protrusio acetabuli (HP:0003179) | 2.59025391 |
| 80 | * Abnormal vertebral ossification (HP:0100569) | 2.58835201 |
| 81 | Polydipsia (HP:0001959) | 2.57820245 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.57820245 |
| 83 | Renal salt wasting (HP:0000127) | 2.49978002 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.45855408 |
| 85 | Vascular calcification (HP:0004934) | 2.41865821 |
| 86 | * Abnormal ossification of hand bones (HP:0005921) | 2.40734435 |
| 87 | * Short femoral neck (HP:0100864) | 2.39686764 |
| 88 | Bell-shaped thorax (HP:0001591) | 2.38631653 |
| 89 | Complement deficiency (HP:0004431) | 2.38111878 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37922928 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37922928 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37922928 |
| 93 | Hyperaldosteronism (HP:0000859) | 2.36579694 |
| 94 | Stillbirth (HP:0003826) | 2.35465579 |
| 95 | Abnormality of renin-angiotensin system (HP:0000847) | 2.32716678 |
| 96 | Vertebral clefting (HP:0008428) | 2.30237579 |
| 97 | * Coxa vara (HP:0002812) | 2.29685395 |
| 98 | * Abnormal hand bone ossification (HP:0010660) | 2.28636236 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 2.27304765 |
| 100 | Achilles tendon contracture (HP:0001771) | 2.26882806 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.26756656 |
| 102 | Chronic otitis media (HP:0000389) | 2.26099206 |
| 103 | Premature rupture of membranes (HP:0001788) | 2.25869003 |
| 104 | Exostoses (HP:0100777) | 2.25104666 |
| 105 | Abnormality of purine metabolism (HP:0004352) | 2.22544120 |
| 106 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.21390124 |
| 107 | * Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.19149404 |
| 108 | Mucopolysacchariduria (HP:0008155) | 2.16979991 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16979991 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14657091 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14657091 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14657091 |
| 113 | Abnormality of complement system (HP:0005339) | 2.13408284 |
| 114 | Renal tubular acidosis (HP:0001947) | 2.12283047 |
| 115 | Abnormality of the pubic bones (HP:0003172) | 2.11957345 |
| 116 | Alkalosis (HP:0001948) | 2.10854580 |
| 117 | Short nail (HP:0001799) | 2.10850896 |
| 118 | * Limited hip movement (HP:0008800) | 2.10591550 |
| 119 | * Hypoplasia of the odontoid process (HP:0003311) | 2.09737019 |
| 120 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.09226912 |
| 121 | Mesomelia (HP:0003027) | 2.08328647 |
| 122 | Ulnar deviation of the wrist (HP:0003049) | 2.08076724 |
| 123 | Nuclear cataract (HP:0100018) | 2.05614166 |
| 124 | * Waddling gait (HP:0002515) | 2.05128000 |
| 125 | Dysostosis multiplex (HP:0000943) | 2.04362504 |
| 126 | Glomerulonephritis (HP:0000099) | 2.01102683 |
| 127 | Lumbar hyperlordosis (HP:0002938) | 1.97816449 |
| 128 | Thoracolumbar scoliosis (HP:0002944) | 1.97581779 |
| 129 | * Hip contracture (HP:0003273) | 1.97346532 |
| 130 | Absent frontal sinuses (HP:0002688) | 1.94707246 |
| 131 | Abnormality of dentin (HP:0010299) | 1.92136613 |
| 132 | * Aplasia/hypoplasia of the femur (HP:0005613) | 1.90590329 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.90492778 |
| 134 | Advanced eruption of teeth (HP:0006288) | 1.90240550 |
| 135 | Hepatoblastoma (HP:0002884) | 1.88655737 |
| 136 | Limited elbow extension (HP:0001377) | 1.87433907 |
| 137 | Tibial bowing (HP:0002982) | 1.86796187 |
| 138 | Femoral bowing (HP:0002980) | 1.85110014 |
| 139 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.84301382 |
| 140 | J-shaped sella turcica (HP:0002680) | 1.83523196 |
| 141 | * Barrel-shaped chest (HP:0001552) | 1.83516038 |
| 142 | Vertebral compression fractures (HP:0002953) | 1.83334972 |
| 143 | Purpura (HP:0000979) | 1.82573932 |
| 144 | * Abnormality of the odontoid process (HP:0003310) | 1.82501980 |
| 145 | Thin bony cortex (HP:0002753) | 1.82273011 |
| 146 | Mitral stenosis (HP:0001718) | 1.80467681 |
| 147 | Mixed hearing impairment (HP:0000410) | 1.80206373 |
| 148 | Ulnar bowing (HP:0003031) | 1.77647688 |
| 149 | Abnormality of the 2nd finger (HP:0004100) | 1.77545470 |
| 150 | Enlarged kidneys (HP:0000105) | 1.76979495 |
| 151 | Increased cerebral lipofuscin (HP:0011813) | 1.74284764 |
| 152 | Tubulointerstitial nephritis (HP:0001970) | 1.70061980 |
| 153 | Xanthomatosis (HP:0000991) | 1.69132496 |
| 154 | Cerebral aneurysm (HP:0004944) | 1.68534463 |
| 155 | Neurofibrillary tangles (HP:0002185) | 1.66991159 |
| 156 | Loss of speech (HP:0002371) | 1.65680267 |
| 157 | Natal tooth (HP:0000695) | 1.65219999 |
| 158 | Long toe (HP:0010511) | 1.65006397 |
| 159 | Myocardial infarction (HP:0001658) | 1.64799964 |
| 160 | Cystic liver disease (HP:0006706) | 1.63282841 |
| 161 | Malnutrition (HP:0004395) | 1.63239838 |
| 162 | * Upper limb amyotrophy (HP:0009129) | 1.61682860 |
| 163 | * Distal upper limb amyotrophy (HP:0007149) | 1.61682860 |
| 164 | Nephritis (HP:0000123) | 1.59568539 |
| 165 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.57488459 |
| 166 | Vascular tortuosity (HP:0004948) | 1.57200156 |
| 167 | Glucose intolerance (HP:0000833) | 1.56165450 |
| 168 | Lip pit (HP:0100267) | 1.54851625 |
| 169 | Arterial tortuosity (HP:0005116) | 1.54393896 |
| 170 | Joint stiffness (HP:0001387) | 1.52816538 |
| 171 | Atrophic scars (HP:0001075) | 1.50843430 |
| 172 | Broad face (HP:0000283) | 1.49827633 |
| 173 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.49380764 |
| 174 | Shallow orbits (HP:0000586) | 1.48479869 |
| 175 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.44427842 |
| 176 | * Hand muscle atrophy (HP:0009130) | 1.41076068 |
| 177 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.39380152 |
| 178 | Hypoalphalipoproteinemia (HP:0003233) | 1.39362873 |
| 179 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.38340670 |
| 180 | Thick nail (HP:0001805) | 1.37612844 |
| 181 | Bifid scrotum (HP:0000048) | 1.36189798 |
| 182 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.35265029 |
| 183 | Aneurysm (HP:0002617) | 1.32804008 |
| 184 | Thoracic kyphosis (HP:0002942) | 1.31057655 |
| 185 | Abnormality of molar (HP:0011077) | 1.29209747 |
| 186 | Abnormality of molar morphology (HP:0011070) | 1.29209747 |
| 187 | Abnormality of the dental root (HP:0006486) | 1.27482225 |
| 188 | Taurodontia (HP:0000679) | 1.27482225 |
| 189 | Abnormality of permanent molar morphology (HP:0011071) | 1.27482225 |
| 190 | Polygenic inheritance (HP:0010982) | 1.26912613 |
| 191 | Amyloidosis (HP:0011034) | 1.25830932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 6.50825134 |
| 2 | DDR2 | 5.47666221 |
| 3 | WNK3 | 4.84126576 |
| 4 | OXSR1 | 4.57505569 |
| 5 | STK38L | 3.70204579 |
| 6 | MAP3K3 | 3.69634924 |
| 7 | STK39 | 3.09159106 |
| 8 | SMG1 | 2.66260733 |
| 9 | PRKG2 | 2.44859811 |
| 10 | MST4 | 2.42440632 |
| 11 | EPHB1 | 2.01998858 |
| 12 | EPHA2 | 1.99526021 |
| 13 | MAPKAPK3 | 1.93792576 |
| 14 | TGFBR2 | 1.83551729 |
| 15 | ICK | 1.82535500 |
| 16 | TTN | 1.76982977 |
| 17 | EPHB2 | 1.74530173 |
| 18 | MAP3K6 | 1.65935135 |
| 19 | EEF2K | 1.59849746 |
| 20 | TESK1 | 1.58185648 |
| 21 | MAP3K7 | 1.56293447 |
| 22 | TRPM7 | 1.55735513 |
| 23 | MST1R | 1.53788620 |
| 24 | WNK1 | 1.49098478 |
| 25 | LATS1 | 1.46177450 |
| 26 | CDC42BPA | 1.41787320 |
| 27 | PDK2 | 1.40418290 |
| 28 | CDK12 | 1.27202854 |
| 29 | MAP3K13 | 1.25957577 |
| 30 | TIE1 | 1.24512366 |
| 31 | RIPK1 | 1.22987436 |
| 32 | PAK4 | 1.22854156 |
| 33 | ERBB3 | 1.22375505 |
| 34 | STK24 | 1.19940169 |
| 35 | SIK1 | 1.17676299 |
| 36 | TRIB3 | 1.12337820 |
| 37 | MARK2 | 1.08187203 |
| 38 | NME1 | 1.06504547 |
| 39 | LRRK2 | 1.00750435 |
| 40 | SGK494 | 0.99947926 |
| 41 | SGK223 | 0.99947926 |
| 42 | ARAF | 0.99145346 |
| 43 | IRAK3 | 0.97287647 |
| 44 | ZAP70 | 0.96898476 |
| 45 | GSK3A | 0.95820184 |
| 46 | PIM2 | 0.95621843 |
| 47 | PKN2 | 0.93611229 |
| 48 | PTK2 | 0.91044025 |
| 49 | MAP3K11 | 0.90544753 |
| 50 | FER | 0.89348787 |
| 51 | ERN1 | 0.87382520 |
| 52 | STK10 | 0.86729639 |
| 53 | MET | 0.84443195 |
| 54 | TTK | 0.82385391 |
| 55 | BCKDK | 0.81117602 |
| 56 | PDPK1 | 0.80837315 |
| 57 | ROCK1 | 0.80467335 |
| 58 | TAOK2 | 0.79648283 |
| 59 | NUAK1 | 0.79081298 |
| 60 | EPHA3 | 0.78969164 |
| 61 | STK3 | 0.78905482 |
| 62 | MAP3K14 | 0.77930088 |
| 63 | TAOK1 | 0.74555397 |
| 64 | MAP2K3 | 0.73770566 |
| 65 | PTK6 | 0.73757812 |
| 66 | LMTK2 | 0.72324281 |
| 67 | MAP3K1 | 0.71093849 |
| 68 | RPS6KA2 | 0.68781461 |
| 69 | MAPK15 | 0.67797839 |
| 70 | ERBB4 | 0.66086651 |
| 71 | FRK | 0.65143228 |
| 72 | NTRK1 | 0.64383017 |
| 73 | STK38 | 0.64304135 |
| 74 | SGK3 | 0.63891625 |
| 75 | CLK1 | 0.63227586 |
| 76 | PRKCI | 0.61818259 |
| 77 | MYLK | 0.61420257 |
| 78 | DYRK1B | 0.61377658 |
| 79 | BLK | 0.58586106 |
| 80 | NEK9 | 0.56613106 |
| 81 | SGK2 | 0.55618549 |
| 82 | PTK2B | 0.54965410 |
| 83 | ERBB2 | 0.53614255 |
| 84 | BMX | 0.53041690 |
| 85 | PDGFRB | 0.51777010 |
| 86 | FGFR4 | 0.51389774 |
| 87 | PDK3 | 0.50677938 |
| 88 | PDK4 | 0.50677938 |
| 89 | MOS | 0.48330592 |
| 90 | MAP3K8 | 0.47302837 |
| 91 | PRPF4B | 0.44880146 |
| 92 | JAK1 | 0.44530179 |
| 93 | CAMK1D | 0.44429946 |
| 94 | HIPK2 | 0.41172695 |
| 95 | CHUK | 0.39755888 |
| 96 | LATS2 | 0.39138382 |
| 97 | PLK2 | 0.37448037 |
| 98 | MAPK12 | 0.36605700 |
| 99 | PIK3CA | 0.35888526 |
| 100 | PAK3 | 0.35045606 |
| 101 | TGFBR1 | 0.35001914 |
| 102 | RET | 0.34393990 |
| 103 | CAMK1G | 0.34387239 |
| 104 | MUSK | 0.32482895 |
| 105 | TBK1 | 0.32448102 |
| 106 | MATK | 0.31304849 |
| 107 | LIMK1 | 0.31262260 |
| 108 | ROCK2 | 0.30343194 |
| 109 | IGF1R | 0.30201243 |
| 110 | PAK2 | 0.29669124 |
| 111 | ABL2 | 0.28719133 |
| 112 | FGFR3 | 0.28373380 |
| 113 | ILK | 0.27914740 |
| 114 | RPS6KL1 | 0.27691030 |
| 115 | RPS6KC1 | 0.27691030 |
| 116 | ABL1 | 0.27409096 |
| 117 | MAPK7 | 0.27178159 |
| 118 | IKBKB | 0.27126578 |
| 119 | CAMK2G | 0.26620073 |
| 120 | FGFR1 | 0.25899584 |
| 121 | INSR | 0.25839345 |
| 122 | PAK1 | 0.25816979 |
| 123 | MAP2K1 | 0.24917858 |
| 124 | AKT2 | 0.24648029 |
| 125 | * SRC | 0.24312393 |
| 126 | CDK9 | 0.23804085 |
| 127 | MAP2K2 | 0.23472507 |
| 128 | MAPK4 | 0.23458803 |
| 129 | PRKCE | 0.23375468 |
| 130 | PRKCH | 0.22684390 |
| 131 | MAP3K2 | 0.21496000 |
| 132 | NME2 | 0.21077828 |
| 133 | PRKD2 | 0.20650882 |
| 134 | CSF1R | 0.20011603 |
| 135 | PIM1 | 0.20010250 |
| 136 | PRKAA2 | 0.19464070 |
| 137 | PDGFRA | 0.19431554 |
| 138 | CSK | 0.16757266 |
| 139 | NEK6 | 0.16601545 |
| 140 | TYK2 | 0.16296666 |
| 141 | * PRKCD | 0.15430367 |
| 142 | * SGK1 | 0.14624665 |
| 143 | TEC | 0.14437491 |
| 144 | EGFR | 0.13509231 |
| 145 | MTOR | 0.11157916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.94681657 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.52668135 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.14988088 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.90806183 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.90069506 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.78704568 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.77268348 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75948481 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.70244657 |
| 10 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.54126919 |
| 11 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.35382814 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26779816 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18165865 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10668561 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95247808 |
| 16 | Mineral absorption_Homo sapiens_hsa04978 | 1.91929291 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89742182 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.88308483 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.86344386 |
| 20 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.71183515 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.69689719 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66593279 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64774967 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59743209 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.59365016 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.57071556 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.55640205 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53510710 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51650964 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.51541011 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.41580547 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.40047847 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39049249 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.37769765 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.36500841 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35903711 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.30893050 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27211033 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.25549843 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20898884 |
| 41 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.16013810 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.15959329 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.15248561 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14097417 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10326283 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 1.10196506 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08489288 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00351762 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95585212 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93730776 |
| 51 | Malaria_Homo sapiens_hsa05144 | 0.93612794 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.90451936 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88576582 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.85992244 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85729867 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84852824 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.83628119 |
| 58 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.81004007 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80831974 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.77327710 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76262902 |
| 62 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.73978972 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73919067 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73628815 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73520300 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72875016 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70514379 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.69443368 |
| 69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68820946 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68446170 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67679249 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67228739 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66891443 |
| 74 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65299231 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65111677 |
| 76 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64884555 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63670478 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.60784619 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60437353 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58826129 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57168956 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57119480 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56602715 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56274997 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54827415 |
| 86 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54113910 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52909378 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51888096 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48519337 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47350426 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44871173 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44117315 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43276374 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42736380 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41946674 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40810904 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39893508 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39689616 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38558308 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38043573 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37822444 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37211994 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36345132 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36288764 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35933334 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.34533573 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.34430846 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33960362 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33403736 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32819887 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31317174 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31109696 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31023058 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30472222 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29867929 |
| 116 | Tuberculosis_Homo sapiens_hsa05152 | 0.29484703 |
| 117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29361548 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.29075369 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.28106755 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28064754 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27157438 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27148228 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.26673386 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26388329 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26380741 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26173811 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25625677 |
| 128 | Leishmaniasis_Homo sapiens_hsa05140 | 0.25049059 |
| 129 | Tight junction_Homo sapiens_hsa04530 | 0.24067466 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.21530746 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20941436 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20327240 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20082649 |

